Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Primary left ventricular unloading with delayed reperfusion in patients with anterior ST-elevation myocardial infarction: Rationale and design of the STEMI-DTU randomized pivotal trial.
Kapur NK, Kim RJ, Moses JW, Stone GW, Udelson JE, Ben-Yehuda O, Redfors B, Issever MO, Josephy N, Polak SJ, O'Neill WW. Kapur NK, et al. Among authors: issever mo. Am Heart J. 2022 Dec;254:122-132. doi: 10.1016/j.ahj.2022.08.011. Epub 2022 Sep 1. Am Heart J. 2022. PMID: 36058253 Clinical Trial.
Percutaneous coronary intervention with ridaforolimus eluting-stents in small vessel coronary artery disease.
Arow Z, Konigstein M, Vaknin-Assa H, Witberg G, Jonas M, Kerner A, Cafri C, Rubinshtein R, Segev A, Roguin A, Issever MO, Gabarin M, Pereg D, Assali A, Koifman E. Arow Z, et al. Among authors: issever mo. Catheter Cardiovasc Interv. 2024 Jan;103(1):61-67. doi: 10.1002/ccd.30924. Epub 2023 Dec 14. Catheter Cardiovasc Interv. 2024. PMID: 38098249 Clinical Trial.
Randomized Comparison of Novel Low-Dose Sirolimus-Eluting Biodegradable Polymer Stent vs Second-Generation DES: TARGET-IV NA Trial.
Yeh RW, Bertrand OF, Mahmud E, Barbato E, Falah B, Issever MO, Redfors B, Popma A, Curtis M, van Royen N, Tanguay JF, Janssens L, Newman WN, Teeuwen K, Choi JW, Dirksen MT, Maehara A, Leon MB. Yeh RW, et al. Among authors: issever mo. J Am Coll Cardiol. 2024 Oct 24:S0735-1097(24)09966-2. doi: 10.1016/j.jacc.2024.10.074. Online ahead of print. J Am Coll Cardiol. 2024. PMID: 39480379
Percutaneous Coronary Interventions Using a Ridaforolimus-Eluting Stent in Patients at High Bleeding Risk.
Kornowski R, Konigstein M, Jonas M, Assali A, Vaknin-Assa H, Segev A, Danenberg H, Halabi M, Roguin A, Kerner A, Lev E, Karamasis GV, Johnson TW, Anderson R, Blaxill J, Jadhav S, Hoole S, Witberg G, Issever MO, Ben-Yehuda O, Baumbach A. Kornowski R, et al. Among authors: issever mo. J Am Heart Assoc. 2024 Jan 16;13(2):e029051. doi: 10.1161/JAHA.122.029051. Epub 2024 Jan 12. J Am Heart Assoc. 2024. PMID: 38214256 Free PMC article. Clinical Trial.
The Supreme Biodegradable Polymer DES in Acute and Chronic Coronary Syndromes: A PIONEER III Substudy.
Hussain Y, Saito S, Curtis M, Kereiakes DJ, Baumbach A, Zidar JP, McLaurin B, Dib N, Smits PC, Jiménez Díaz VA, Cequier Á, Hofma SH, Pietras C, Dressler O, Issever MO, Windecker S, Leon MB, Lansky AJ; PIONEER III Trial Investigators. Hussain Y, et al. Among authors: issever mo. J Soc Cardiovasc Angiogr Interv. 2023 Mar 27;2(3):100629. doi: 10.1016/j.jscai.2023.100629. eCollection 2023 May-Jun. J Soc Cardiovasc Angiogr Interv. 2023. PMID: 39130696 Free PMC article.
Geographic Variations on the Safety and Efficacy of the Supreme Biodegradable Polymer DES: Results From PIONEER III.
Garot P, Leon MB, Saito S, Baumbach A, Kereiakes DJ, Windecker S, Pietras C, Dressler O, Issever MO, Curtis M, Bertolet BD, Zidar JP, Smits PC, Jiménez Diaz VA, McLaurin B, Cequier AR, Hofma SH, Dib N, Namiki A, Takahashi A, Kakuta T, Hirohata A, Lansky AJ. Garot P, et al. Among authors: issever mo. J Soc Cardiovasc Angiogr Interv. 2022 Nov 25;2(1):100515. doi: 10.1016/j.jscai.2022.100515. eCollection 2023 Jan-Feb. J Soc Cardiovasc Angiogr Interv. 2022. PMID: 39132534 Free PMC article.
Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitus.
Thomas A, Kereiakes DJ, Baumbach A, Windecker S, Pietras C, Dressler O, Issever MO, Curtis M, Bertolet B, Zidar JP, Smits PC, Jiménez Díaz VA, McLaurin B, Cequier Á, Takahashi A, Cannon LA, Amoroso G, Kakuta T, Saito S, Leon MB, Lansky AJ. Thomas A, et al. Among authors: issever mo. J Soc Cardiovasc Angiogr Interv. 2022 Apr 11;1(2):100033. doi: 10.1016/j.jscai.2022.100033. eCollection 2022 Mar-Apr. J Soc Cardiovasc Angiogr Interv. 2022. PMID: 39132558 Free PMC article.
Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy.
Patel KP, Lansky AJ, Kereiakes DJ, Windecker S, Cristea E, Pietras C, Dressler O, Issever MO, Curtis M, Bertolet B, Zidar JP, Smits PC, Jiménez Díaz VA, McLaurin B, Brogno DA, Janssens L, Vrolix MC, Gómez-Blázquez I, Sahul ZH, Kabour A, Salido L, Cleman M, Saito S, Leon MB, Baumbach A; PIONEER III Trial Investigators. Patel KP, et al. Among authors: issever mo. J Soc Cardiovasc Angiogr Interv. 2022 Jan 30;1(1):100004. doi: 10.1016/j.jscai.2021.100004. eCollection 2022 Jan-Feb. J Soc Cardiovasc Angiogr Interv. 2022. PMID: 39130138 Free PMC article.